Clinical Trial Update: An Escalating Dose Indomethacin for the Treatment of Persistent Patent Ductus Arteriosus (PDA) In Preterm Infants [Phase 2, Phase 3]

View source ↗

Summary

The document describes escalating-dose indomethacin trials for treating persistent patent ductus arteriosus in preterm infants, across Phase 2 and Phase 3. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Patent Ductus Arteriosus

Drugs mentioned

• INDOMETHACIN (INDOMETHACIN)

Snippet

Sponsor: University of Calgary | Conditions: Patent Ductus Arteriosus | Phase 2, Phase 3 | Status: TERMINATED